Clinical Trials Logo
  1. Home
  2. Amblyopia
  3. NCT03447171
  4. Details
NCT03447171 Clinical Trial

Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children

Amblyopia Clinical Trial

Official title:
Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03447171
Other study ID # 2018-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 7, 2018
Est. completion date June 4, 2018

Study information
Verified date August 2018
Source Gobiquity Mobile Health
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective is evaluation of GoCheck Kids, a smartphone application ('App'), for use as a photo screening device in a pediatric population to detect amblyopia risk factors (ARFs).

Description:

Detection of amblyopia risk factors using photo screening app in children of ages from 12 months to 8 years

Recruitment information / eligibility
Status Completed
Enrollment 207
Est. completion date June 4, 2018
Est. primary completion date June 4, 2018
Accepts healthy volunteers No
Gender All
Age group 1 Year to 8 Years
Eligibility Inclusion Criteria:

- Age 12 months to 8 years inclusive.

- Informed consent given by parent or legal guardian.

Exclusion Criteria:

- History of ocular surgery and any condition that would preclude the ability of the investigator to obtain a reliable image and measurement

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• App Vision Screening
Using GoCheck Kids App Vision Screening to detect Amblyopia Risk Factors

Locations
Country Name City State
United States Alaska Children's Eye & Strabismus Anchorage Alaska

Sponsors (1)
Lead Sponsor Collaborator
Gobiquity Mobile Health

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Sensitivity and specificity of amblyopia risk factors detected by Photorefraction Identification of risk factors compared to gold standard cycloplegic refraction 1 day
Secondary Number of patients with gaze error identified by photo screening Detection of gaze error compared to cover test examination results 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT04238065 - A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia N/A
Completed NCT04432181 - Comparison of Deviation Types Among Astigmatic Children With Or Without Amblyopia
Terminated NCT02767856 - Regimens of Intermittent Occlusion Therapy for Amblyopia in Children N/A
Completed NCT02458846 - Efficacy of Visual Screening in Ontario N/A
Completed NCT01190813 - Levodopa for the Treatment of Residual Amblyopia Phase 3
Completed NCT01109459 - Multimodal Physician Intervention to Detect Amblyopia N/A
Completed NCT04313257 - Monocular Action Video Game Treatment of Amblyopia N/A
Completed NCT04315649 - Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops N/A
Completed NCT05223153 - OCT-A and Amblyopia
Recruiting NCT05522972 - Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games N/A
Completed NCT01430247 - Vision Screening for the Detection of Amblyopia N/A
Completed NCT02200211 - Study of Binocular Computer Activities for Treatment of Amblyopia N/A
Recruiting NCT06429280 - Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Withdrawn NCT04959422 - Assuring Ophthalmologic Follow up N/A
Active, not recruiting NCT05612568 - 5 Years of Eye Screening for ARF in Children Aged <3 Years in Flanders
Recruiting NCT03655912 - Binocular Visual Therapy and Video Games for Amblyopia Treatment. N/A
Recruiting NCT06150391 - Evaluation of Amblyopia Protocols Using a Dichoptic Gabor Videogame Program N/A
Completed NCT03754153 - Binocularly Balanced Viewing Study N/A
Terminated NCT02246556 - Dichoptic Virtual Reality Therapy for Amblyopia in Adults Phase 1
Withdrawn NCT02594358 - Caffeine in Amblyopia Study Phase 1/Phase 2